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Abstract
Background:  Anal  sphincter  spasm  contributes  to  the  appearance  of  postoperative  pain  follow-
ing hemorrhoidectomy.
Aim:  To  determine  the  efﬁcacy  of  topical  diltiazem  in  the  control  of  post-hemorrhoidectomy
pain.
Material  and  methods:  A  randomized,  prospective,  experimental,  double-blind  study  was  con-
ducted on  2  groups  of  patients  in  the  postoperative  period  of  closed  hemorrhoidectomy.  Each
group consisted  of  17  patients.  Group  A  received  topical  diltiazem  in  the  anal  region  3  times
a day  and  group  B  received  a  placebo.  Ketorolac  was  administered  to  both  groups  as  rescue
therapy.
Results: In  group  A,  the  mean  score  on  the  visual  analog  scale  was  2.97  ±  1.18  cm  at  24  h,
1.51 ±  1.18  cm  at  48  h,  and  0.84  ±  0.92  cm  at  72  h.  In  group  B,  it  was  6.82  ±  1.9  cm  at  24  h,
5.3 ±  1.66  cm  at  48  h,  and  4.32  ±  2.13  cm  at  72  h  (P<.001,  95%  CI).
The mean  number  of  analgesic  doses  in  group  A  was  2.41  ±  0.87  at  24  h,  1.11  ±  0.85  at  48  h,
and 0.94  ±  0.96  at  72  h.  In  group  B,  it  was  3.82  ±  0.52  at  24  h,  3.64  ±  0.70  at  48  h,  and  2.88  ±  1.26
at 72  h  (P<.001,  95%  CI). Please cite this article as: Rodríguez-Wong U, Ocharán-Hernández ME, Toscano-Garibay J. Diltiazem tópico en el dolor postoperatorio de
emorroidectomía con técnica cerrada. Revista de Gastroenterología de México. 2016;82:74--79.
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Conclusions:  In  this  study,  topical  administration  of  diltiazem  resulted  in  a  statistically  signiﬁ-
cant reduction  of  postoperative  pain  in  patients  that  underwent  closed  hemorrhoidectomy.
© 2016  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Diltiazem  tópico  en  el  dolor  postoperatorio  de  hemorroidectomía  con  técnica  cerrada
Resumen
Antecedentes:  El  espasmo  del  esfínter  anal  contribuye  a  la  aparición  del  dolor  postoperatorio
después  de  una  hemorroidectomía.
Objetivo:  Determinar  la  eﬁcacia  del  diltiazem  tópico  en  el  control  del  dolor  postoperatorio  de
hemorroidectomía.
Material y  métodos:  Se  realizó  un  estudio  aleatorizado,  prospectivo,  experimental,  doble
ciego, en  2  grupos  de  pacientes  en  el  postoperatorio  de  hemorroidectomía  con  técnica  ce-
rrada. Cada  grupo  incluyo  a  17  pacientes,  el  grupo  A  recibió  diltiazem  tópico  en  la  región  anal
3 veces  al  día  y  el  grupo  B  recibió  un  placebo.  En  ambos  grupos  se  administró  ketorolaco  por
vía oral  como  terapia  de  rescate.
Resultados:  En  el  grupo  A  el  promedio  de  caliﬁcación  de  la  escala  análoga  visual  fue  de
2.97 ±  1.18  cm  a  las  24  h,  1.51  ±  1.18  cm  a  las  48  h  y  0.84  ±  0.92  cm  a  las  72  h.  En  el  grupo
B fue  de  6.82  ±  1.9  cm  a  las  24  h,  5.3  ±  1.66  cm  a  las  48  h  y  4.32  ±  2.13  cm  a  las  72  h  (p  <  0.001,
IC del  95%).
El  promedio  de  número  de  dosis  de  analgésico  en  el  grupo  A  fue  de  2.41  ±  0.87  a
las 24  h,  1.11  ±  0.85  a  las  48  h  y  0.94  ±  0.96  a  las  72  h.  En  el  grupo  B  fue  de  3.82  ±  0.52
dosis a  las  24  h,  3.64  ±  0.70  dosis  a  las  48  h  y  2.88  ±  1.26  a  las  72  h  (p  <  0.001,  IC  del  95%).
Conclusiones:  En  este  estudio,  el  diltiazem  administrado  por  vía  tópica  disminuyó  el  dolor,  en  los
pacientes  postoperados  de  hemorroidectomía  con  técnica  cerrada,  de  manera  estadísticamente
signiﬁcativa.
© 2016  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.  Este
es un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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The  non-inclusion  criteria  were:  patients  under  treat-Introduction
Seventy-seven  percent  of  patients  are  estimated  to  present
with  pain  after  a  surgical  procedure  and  of  those,  80%  refer
to  it  as  moderate-to-severe  intensity.1 The  pain  associated
with  the  surgical  treatment  of  hemorrhoidal  disease  is  not
considered  a  complication  of  this  procedure  in  itself,  but  it
is  the  main  reason  why  patients  with  hemorrhoidal  disease
avoid  treatment.2
For  the  purpose  of  reducing  pain  in  the  treatment  of
hemorrhoidal  disease,  attempts  have  been  made  to  improve
the  surgical  techniques,  analgesic  procedures,  and  general
postoperative  management  measures.3
In  virtue  of  the  fact  that  anal  sphincter  spasm  could
play  an  important  role  in  the  appearance  of  postoperative
pain  after  hemorrhoidectomy,  partial  anal  sphincter  sphinc-
terotomy  has  been  suggested  as  an  alternative  for  reducing
this  pain.4 Even  though  some  authors  state  that  there
are  no  signiﬁcant  differences  in  relation  to  anal  sphincter
continence,  when  sphincterotomy  is  added  during  hemor-
rhoidectomy,  the  risk  for  anal  incontinence  in  these  patients
is  high.  Therefore,  sphincterotomy  is  not  recommended  in
the  postoperative  period  of  hemorrhoidectomy,  unless  there
is  an  associated  anal  ﬁssure.2 In  an  effort  to  prevent  this
m
c
oomplication,  some  topical  medications,  such  as  nitroglyc-
rine,  botulinum  toxin,  and  diltiazem  (DTZ),  have  been  used
o  relax  the  anal  sphincter  and  reduce  pain.5
The  aim  of  this  work  was  to  determine  the  efﬁcacy  of
opical  diltiazem  in  the  control  of  post-hemorrhoidectomy
ain.
ethods
 simple,  randomized,  experimental,  prospective,  longitu-
inal,  and  double-blind  study  was  conducted.  All  34  patients
hat  underwent  the  Ferguson  closed  hemorrhoidectomy  for
rade  III  and  grade  IV  hemorrhoidal  disease  were  operated
n  by  the  same  surgeon.  The  patients  were  randomly  divided
nto  2  groups  of  17  patients  each.
The  inclusion  criteria  were:  patients  with  grade  III  and
rade  IV  hemorrhoidal  disease  and  mixed  hemorrhoidal
isease  that  were  surgically  treated  through  closed  hem-
rrhoidectomy.ent  with  calcium  channel  blocking  agents,  patients  that
omplained  of  previous  collateral  effects  with  the  use
f  calcium  channel  blockers,  and  patients  with  a history
7 U.  Rodríguez-Wong  et  al.
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Sample
34 patients in two groups
-Inclusion criteria
-Exclusion criteria
-Elimination criteria
Signed informed consent
Measurement no. 1 at 24 h VAS pain
Measurement no. 2 at 48 h VAS pain
Measurement no. 3 at 72 h VAS pain
Data collection
Result analysis
DTZ treatment group
17 patients
Control group
17 patients
Simple
randomization
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f  ischemic  heart  disease,  pregnancy,  severe  high  blood
ressure,  and  orthostatic  hypotension.
The  exclusion  criteria  were  applied  as  follows:  patients
ith  hemorrhoidal  disease  grades  I  and  II  and  patients
ith  hemorrhoidal  disease  grades  III  and  IV  that  were
reated  with  some  other  surgical  procedure  (circular  sta-
ler,  transanal  dearterialization,  open  hemorrhoidectomy).
inally,  the  elimination  criteria  corresponded  to  patients
hat  did  not  give  their  informed  consent.
The  sample  size  of  this  study  took  into  account  that
he  current  worldwide  estimate  of  hemorrhoidal  disease
n  the  general  population  is  6%.  Nevertheless,  it  is  cal-
ulated  that  with  the  use  of  conservative  measures  and
onsurgical  treatment  procedures  such  as  elastic  band  lig-
ture,  infrared  photocoagulation,  and  sclerotherapy,  only
 quarter  of  the  patients  presenting  with  hemorrhoidal
isease  will  require  some  type  of  surgical  treatment.  In
ther  words,  only  1.5%  of  the  general  population  will
equire  some  type  of  surgical  procedure.  Closed  hemor-
hoidectomy  is  currently  the  most  frequently  performed
urgical  procedure  for  the  treatment  of  hemorrhoidal  dis-
ase,  used  in  70%  of  the  cases.  This  implies  that  of  the
.5%  of  patients  requiring  surgical  treatment,  only  70%
ill  be  operated  on  with  the  closed  technique.  That  is  to
ay,  0.0105%  of  the  population  will  require  closed  hem-
rrhoidectomy  and  therefore  the  p  value  (the  population
resenting  with  the  characteristic)  in  this  study  was  equal
o  0.0105.  The  Z  value  for  calculating  sample  size  was
.96.
Topical  diltiazem  (gel  at  2%)  was  administered  to  group
 in  the  immediate  postoperative  period  (when  the  anes-
hetic  effect  ended)  and  treatment  was  continued  for  72  h,
dministering  the  medication  in  the  same  manner  3  times
 day.  Placebo  was  administered  to  group  B  with  the  same
ndications  used  in  group  A.
Both  the  diltiazem  gel  at  2%  and  the  placebo  had  the
ame  physical  characteristics  and  they  were  presented  to
he  patients  in  a  dosing  syringe.  They  were  instructed  to
pply  0.5  ml  of  the  product  in  the  anal  region,  the  equivalent
f  10  mg  per  dose.  Because  the  analysis  was  a  double-blind
tudy,  neither  the  patient  nor  the  researcher  knew  which
yringes  contained  diltiazem  or  placebo.
The  syringes  were  marked  with  progressive  numbers  and
andomly  assigned  to  each  patient,  with  no  knowledge  of
he  contents.  An  independent  assistant  made  a  list  identi-
ying  the  syringes  that  contained  diltiazem  and  those  that
ontained  placebo,  and  did  not  reveal  that  information  to
nyone.  The  list  was  kept  in  a  closed  envelope  until  the  end
f  the  study.
Both  groups  received  the  standard  treatment  for  pain
ontrol  in  the  postoperative  period  of  the  hemorrhoidec-
omy  during  the  time  of  the  study:  sitz  baths  in  warm  water
very  6  h  and  10  mg  of  oral  ketorolac  every  6  h  in  the  event
f  pain.
The  results  were  evaluated  through  the  visual  analog
cale  (VAS)  on  a  straight  line  from  0  to  10  by  the  patients
hemselves  for  quantifying  pain  intensity.  Pain  was  measured
t  24,  48,  and  72  h.Rescue  therapy  for  pain  in  the  postoperative  closed  hem-
rrhoidectomy  period  was  registered  by  writing  down  the
oses  of  ketorolac  required  by  the  patients  at  24,  48,  and
2  h.
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tFigure  1  Flowchart  of  the  study.
This  study  was  approved  by  the  Ethics  Committee  and  the
esearch  and  Teaching  Administration  of  the  Hospital  Juárez
e  México  number  HJM2146/12-A  and  was  carried  out  at  the
ospital  Juárez  de  México  and  the  Postgraduate  Studies  and
esearch  Section  of  the  School  of  Medicine  of  the  Instituto
olitécnico  Nacional.
Statistical  analysis:  The  Mann-Whitney  U  test  was  used
o  determine  whether  there  were  differences  in  age  and
ex  between  the  two  groups.  The  postoperative  patient  VAS
alues  and  number  of  analgesic  doses  were  analyzed  by  the
ariance  analysis  test  (ANOVA).  Figure  1 shows  the  ﬂowchart
f  the  study.
esults
ineteen  of  the  study  patients  were  men  and  15  were
omen.  Their  mean  age  was  45.67  years  with  a range  of
8  to  74  years.
The  mean  age  of  the  patients  in  the  control  group
as  44.77  years  and  it  was  46.59  years  in  the  diltiazem
roup.  There  was  no  statistically  signiﬁcant  difference  in
ge  between  the  two  groups  p  =  0.657,  with  a  95%  conﬁdence
nterval  (CI).  In  the  control  group,  6  patients  were  women
nd  11  were  men,  and  in  the  diltiazem  group  9  patients  were
omen  and  8  were  men.  There  was  no  statistically  signiﬁ-
ant  difference  in  relation  to  sex  between  the  two  groups
 = 0.317,  with  a  95%  CI  (Mann-Whitney  U  test)  (table  1).
The  mean  VAS  value  in  the  control  group  was
.82  ±  1.9  cm  at  24  h,  5.3  ±  1.66  cm  at  48  h,  and.32  ±  2.13  cm  at  72  h,  and  it  was  2.97  ±  1.18  cm  at
4  h,  1.51  ±  1.18  cm  at  48  h,  and  0.84  ±  0.92  cm  at  72  h  in
he  diltiazem  group  (table  2).
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Table  1  Demographic  characteristics.
Patients  Women  Men  Mean  age
Control  group  17  6  11  44.77
Diltiazem  group  17  9  8  46.59
Table  2  Mean  Visual  Analog  Scale  values.
24  h 48  h 72  h
Control  group  6.82  5.3  4.32
Diltiazem  group  2.97  1.51  0.84
p < 0.001, 95% CI
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Figure  2  Comparison  of  the  visual  analog  scale  (VAS)  values
4.5
4.0
3.5
3.0
2.5
N
um
be
r o
f d
os
es
2.0
1.5
1.0
0.5
483624
Hours
Diltiazem
*
*
*
Control
7260
Figure  3  Comparison  of  the  number  of  analgesic  doses  for
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abetween  the  control  group  and  the  group  treated  with  diltiazem
(p <  0.001,  95%  CI).
The  statistical  analysis  for  the  VAS  values  between  the
two  groups  was  carried  out  with  the  ANOVA  test,  ﬁnding  a  p
<  0.001  with  a  95%  CI  (ﬁg.  2).
The  mean  number  of  analgesic  doses  used  in  the  control
group  was  3.82  ±  0.52  doses  at  24  h,  3.64  ±  0.70  doses  at
48  h,  and  2.88  ±  1.26  at  72  h,  and  it  was  2.41  ±  0.87  at  24  h,
1.11  ±  0.85  at  48  h,  and  0.94  ±  0.96  at  72  h  in  the  diltiazem
group  (table  3).  The  ANOVA  test  was  also  used  in  the  statis-
tical  analysis  for  comparing  the  number  of  doses  between
the  2  groups,  ﬁnding  a  p  <  0.001  with  a  95%  CI  (ﬁg.  3).
No  adverse  reactions  were  observed  in  any  of  the  patients
in  the  control  group  or  the  diltiazem  group  during  the  time
of  the  study.
Given  that  the  sample  included  older  adult  patients,  to
prevent  toxicity  secondary  to  the  use  of  ketorolac  as  rescue
therapy,  the  study  was  not  extended  for  a  longer  period  of
time.
Table  3  Mean  number  of  analgesic  doses.
24  h  48  h  72  h
Control  group  3.82  3.64  2.88
Diltiazem  group  2.41  1.11  0.94
p < 0.001, 95% CI.
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wvery 24  h  between  the  control  group  and  the  group  treated
ith diltiazem  (p  <  0.001,  95%  CI).
iscussion
losed  hemorrhoidectomy  with  the  Ferguson  technique  con-
inues  to  be  the  best  treatment  for  hemorrhoidal  disease,
ith  a low  recurrence  rate  and  a  greater  patient  satisfac-
ion  rate  in  relation  to  results.6 Postoperative  pain  following
emorrhoidectomy  is  considered  one  of  the  25  main  causes
f  postoperative  pain.7
Topical  nitroglycerine  has  been  shown  to  reduce  pain  in
he  postoperative  period  of  patients  that  underwent  hem-
rrhoidectomy.  However,  it  is  associated  with  a  greater
ncidence  of  side  effects,  the  most  bothersome  of  which  is
eadache.  Wasvary  et  al.8 conducted  a  randomized  study  on
9  patients  divided  into  2  groups  for  evaluating  the  efﬁcacy
f  topical  nitroglycerine  at  0.2%  in  the  control  of  postop-
rative  pain  after  hemorrhoidectomy.  Topical  nitroglycerine
as  administered  to  a  group  of  19  patients  and  placebo  was
iven  to  the  control  group  of  20  patients.  The  authors  found
hat  topical  nitroglycerine  at  0.2%  reduced  the  analgesic
oses  with  statistical  signiﬁcance  on  the  second  postop-
rative  day.  However,  8  of  the  19  patients  treated  with
opical  nitroglycerine  presented  with  headache,  resulting  in
reater  morbidity  in  this  group,  compared  with  the  control
roup  (p  <  0.05).  In  a  more  recent  study  by  Karanlik  et  al.,9
 groups  of  30  patients  each  were  evaluated.  One  group  used
opical  nitroglycerine  at  0.2%  and  the  other  placebo.  There
ere  signiﬁcant  differences  in  the  reduction  of  postopera-
ive  pain  following  hemorrhoidectomy  on  the  ﬁrst,  third,
nd  seventh  postoperative  days  (p  <  0.05).  The  authors  also
ound  a  statistically  signiﬁcant  lower  cicatrization  time  in
he  nitroglycerine  group  than  in  the  control  group.  In  a  meta-
nalysis  carried  out  by  Ratnasingham  et  al.10 that  included
 total  of  5  clinical  trials  with  a  total  of  333  patients,  they
ompared  topical  nitroglycerine  against  placebo  for  postop-
rative  pain  reduction  after  hemorrhoidectomy.  The  results
ere  statistically  signiﬁcant  on  postoperative  days  3  and  7
p  of  0.029  and  0.014,  respectively).  Nevertheless,  there
ere  no  signiﬁcant  differences  on  the  ﬁrst  postoperative
ay.  This  meta-analysis  also  showed  that  cicatrization  time
as  reduced  in  patients  that  used  nitroglycerine,  with  an
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dds  ratio  of  3.57  (p  <  0.0001)  at  3  weeks.  No  adverse  reac-
ions,  such  as  headache,  anal  pruritus,  or  perianal  cutaneous
rritation,  were  observed  in  our  patients.
On  the  other  hand,  botulinum  toxin,  which  also  produces
nal  sphincter  relaxation,  could  be  a  useful  alternative  in
ostoperative  pain  reductions  in  patients  undergoing  hemor-
hoidectomy.  In  a  randomized,  double-blind  study  by  Davies
t  al.,11 50  patients  were  divided  into  2  groups  of  patients
aving  undergone  hemorrhoidectomy  with  the  Milligan  and
organ  technique.  Twenty  IU  of  botulinum  toxin  diluted  in
.4  ml  of  saline  solution  were  administered  to  one  group
f  patients  and  only  saline  solution  was  injected  into  the
nternal  anal  sphincter  of  the  control  group  patients.  The
uthors  found  signiﬁcant  differences  in  relation  to  pain
eduction  on  day  6  (p  <  0.05)  and  day  7  (p  <  0.05).  In
nother  study  by  Patti  et  al.,12 the  efﬁcacy  of  botulinum
oxin  was  compared  with  that  of  topical  nitroglycerine
or  reducing  postoperative  pain  in  patients  that  under-
ent  hemorrhoidectomy.  Thirty  patients  were  divided  into
 groups  of  15  patients  each.  Twenty  IU  of  intrasphincteric
otulinum  toxin  was  administered  to  one  group  and  300  mg
f  nitroglycerine  at  2%  was  administered  to  the  other  group
 times  a  day  for  30  days.  The  authors  found  signiﬁcant  dif-
erences  in  relation  to  pain  reduction  in  repose  in  the  group
reated  with  botulinum  toxin.  There  were  no  differences
n  regard  to  pain  during  bowel  movements  or  in  cicatriza-
ion  time.  Headache  presented  as  a  side  effect  only  in  the
roup  treated  with  nitroglycerine.  Despite  the  good  results
ublished,  botulinum  toxin  use  is  an  invasive  and  a  more
xpensive  procedure.  In  our  patients,  the  use  of  topical  dil-
iazem  at  2%  was  not  an  invasive  procedure.
Carapeti  et  al.13 showed  that  topical  diltiazem  reduced
he  maximum  resting  pressure  of  the  internal  anal  sphincter
n  volunteer  healthy  subjects,  reaching  a  greater  effect  at  a
%  concentration.  The  calcium  blockers  administered  orally
educed  anal  pressure,  but  the  required  dose  (60  mg)  was
pproximately  7  to  8  times  higher  than  the  required  dose
hen  applied  topically  (8  to  10  mg).  This  means  that  topical
reatment  has  a  lower  probability  of  causing  systemic  side
ffects.14
Silverman  et  al.15 carried  out  a  randomized,  prospective,
ouble-blind  study  on  18  patients  that  underwent  hemor-
hoidectomy,  dividing  the  patients  into  2  groups  of  9  patients
ach.  Topical  diltiazem  at  2%  in  unguent  form  was  used
n  one  group  and  placebo  in  the  other  group.  The  results
howed  statistically  signiﬁcant  reduced  postoperative  pain
p  <  0.001)  during  the  ﬁrst  7  postoperative  days.  A  more
etailed  analysis  of  their  results  showed  that  this  effect  was
eached  from  days  1  and  2  with  VAS  values  of  5.2  ±  2.4  for
he  diltiazem  group  and  8.8  ±  1.2  for  the  control  group  (p
 0.001).  In  addition,  this  effect  was  maintained  for  the
est  of  the  study.  For  days  3,  4,  and  5,  the  group  treated
ith  diltiazem  had  a  VAS  value  of  3.7  ±  2  and  the  control
roup  had  a  value  of  6.8  ±  2.  For  days  6  and  7,  the  values  in
he  group  treated  with  diltiazem  were  2.3  ±  1.2  and  for  the
ontrol  group  were  5.2  ±  1.7  (p  <  0.001).  Some  of  our  study
esults  coincided  with  those  reported  by  Silverman  et  al.
e  found  a  statistically  signiﬁcant  reduction  in  postopera-ive  pain  after  hemorrhoidectomy  from  the  ﬁrst  day  in  the
roup  treated  with  topical  diltiazem  at  2%,  with  a  mean  VAS
alue  of  2.97  ±  1.2  and  a  value  of  6.82  ±  1.95  for  the  control
roup  (p  <  0.001,  95%  CI).  Likewise  we  observed  that  this
F
NU.  Rodríguez-Wong  et  al.
ffect  was  maintained  for  the  3  days  of  the  study  with  mean
AS  values  on  days  2  and  3  of  1.51  ±  1.16  and  0.84  ±  0.87,
espectively,  in  the  group  treated  with  diltiazem,  and  of
.3  ±  1.68  and  4.32  ±  2.17,  respectively,  in  the  control  group
p  <  0.001,  95%  CI).  Silverman5 found  no  signiﬁcant  differ-
nces  in  the  use  of  analgesics  in  the  postoperative  period
etween  the  group  treated  with  diltiazem  compared  with
he  control  group.  In  contrast,  we  found  signiﬁcant  differ-
nces  in  our  study  in  the  use  of  analgesics  between  the  group
reated  with  topical  diltiazem  and  the  control  group  (p  <
.001,  95%  CI).
In  a  more  recent  randomized  and  prospective  study
y  Chauhan  et  al.16 on  postoperative  hemorrhoidectomy
atients,  they  compared  internal  lateral  sphincterotomy
ith  topical  diltiazem  at  2%  for  the  control  of  postopera-
ive  pain.  They  studied  102  patients  divided  into  2  groups  of
0  and  52  patients.  The  results  showed  a  signiﬁcantly  lower
AS  value  in  patients  that  underwent  internal  lateral  sphinc-
erotomy  versus  those  that  received  topical  diltiazem  at  2%
2.23  vs  3.72;  p  =  0.031).  Likewise,  the  need  for  analgesics
as  lower  in  the  group  treated  with  sphincterotomy  (10.54
s  15.40;  p  =  0.01).  However,  the  incidence  of  complications
as  greater  in  the  group  treated  with  sphincterotomy  (11.5%
s  3%;  p =  0.488).  Despite  the  conclusion  of  the  authors  that
ateral  sphincterotomy  provided  greater  postoperative  pain
eduction  than  diltiazem,  a  higher  number  of  complications
ould  be  a  limiting  factor  for  using  sphincterotomy  as  a  mea-
ure  for  post-hemorrhoidectomy  pain  reduction.
onclusions
he  groups  analyzed  in  this  study  were  comparable  in  rela-
ion  to  age  and  sex.  There  were  signiﬁcant  differences  with
espect  to  the  VAS  values  and  the  number  of  analgesic  doses
etween  the  two  groups,  p  <  0.001  with  a  95%  CI  (utilizing
he  ANOVA  test  for  the  statistical  analysis).
In  our  study,  the  application  of  topical  diltiazem  at
%  reduced  postoperative  pain  in  patients  that  underwent
losed  hemorrhoidectomy,  compared  with  those  that  were
iven  placebo.  The  results  were  clinically  and  statistically
igniﬁcant.
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